Vogkare M 0.2 Tab

Composition

Voglibose 0.2 mg + Metformin Hydrochloride (strength unknown)

Uses of Vogkare M 0.2 Tab

Type 2 diabetes mellitus (as add-on to diet and exercise) to control post-meal and overall blood glucose, especially when single therapy is insufficient.

• •Reduces post-meal blood glucose spikes
• •Improves insulin sensitivity and lowers fasting glucose
• •Helps achieve better HbA1c control
• •May aid weight-neutral glycaemic control compared with some agents

How it works

Voglibose is an alpha-glucosidase inhibitor that delays intestinal carbohydrate digestion and absorption, reducing post-meal blood sugar spikes. Metformin decreases hepatic glucose production and improves insulin sensitivity, helping lower fasting and postprandial glucose.

Directions for use

Oral tablet. Usually taken with meals as prescribed; voglibose-containing combinations are typically taken just before the first bite of a main meal. Swallow whole with water; do not skip meals. Dose and frequency depend on blood sugar control and kidney function.

Side effects

Common side effects of Vogkare M 0.2 Tab may include:

• •Flatulence
• •abdominal pain
• •diarrhea
• •nausea
• •vomiting